Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Loans - Loss Allowance: 2018-2024

Historic Loans - Loss Allowance for HUTCHMED (China) (HCM) over the last 3 years, with Jun 2024 value amounting to $67.0 million.

  • HUTCHMED (China)'s Loans - Loss Allowance fell 11.93% to $67.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $67.0 million, marking a year-over-year decrease of 11.93%. This contributed to the annual value of -$171,000 for FY2023, which is 185.00% down from last year.
  • Latest data reveals that HUTCHMED (China) reported Loans - Loss Allowance of $67.0 million as of Q2 2024, which was up 39,273.68% from -$171,000 recorded in Q4 2023.
  • HUTCHMED (China)'s Loans - Loss Allowance's 5-year high stood at $76.1 million during Q2 2023, with a 5-year trough of -$171,000 in Q4 2023.
  • Moreover, its 3-year median value for Loans - Loss Allowance was $40.0 million (2022), whereas its average is $36.6 million.
  • Data for HUTCHMED (China)'s Loans - Loss Allowance shows a peak YoY increase of 182.68% (in 2022) and a maximum YoY decrease of 200.00% (in 2022) over the last 5 years.
  • HUTCHMED (China)'s Loans - Loss Allowance (Quarterly) stood at -$95,000 in 2020, then spiked by 78.95% to -$20,000 in 2021, then plummeted by 200.00% to -$60,000 in 2022, then slumped by 185.00% to -$171,000 in 2023, then declined by 11.93% to $67.0 million in 2024.
  • Its last three reported values are $67.0 million in Q2 2024, -$171,000 for Q4 2023, and $76.1 million during Q2 2023.